Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis

Journal of Digestive Diseases

Volumn 11, Issue 3, 2010, Pages 167-175

  Xie, Hai Long ^a   Li, Zhi Yu ^c   Gan, Run Liang ^a   Li, Xiao Jie ^b   ZHang, Qing Li ^a   Hui, Mei ^a   Zhou, Xiu Tian ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CAII; CTTN; Gastric carcinoma; IGFBP4; Lymph node metastasis

Indexed keywords

CARBONATE DEHYDRATASE II; CORTACTIN; CTTN PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN 4;

CANCER STAGING; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; PROCEDURES; PROGNOSIS; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; STOMACH TUMOR; UPREGULATION;

CARBONIC ANHYDRASE II; CORTACTIN; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; LYMPHATIC METASTASIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; UP-REGULATION;

EID: 77954106862     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00432.x     Document Type: Article

References (34)

1. Varadhachary G, Ajani JA. Gastric cancer. Clin Adv Hematol Oncol 2005, 3:118-24.
2. Lin J, Beerm DG. Molecular biology of upper gastrointestinal malignancies. Semin Oncol 2004, 31:476-86.
3. Wu CW, Chen GD, Fann CS. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer 2002, 35:219-31.
4. Kim KM, Kwon MS, Hong SJ. Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch 2003, 443:491-500.
5. Liu TF, Yin ZH, Gan RL. Refined mapping of the loss of heterozygosity on chromosome 1q21 in gastric carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2008, 28:1229-32.
6. Kang JU, Kang JJ, Kwon KC. Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J Korean Med Sci 2006, 21:656-65.
7. Weiss MM, Kuipers EJ, Postma C. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 2004, 26:307-17.
8. Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y. Indications of limited surgery for gastric cancer with submucosal invasion - analysis of 715 cases with special reference to site of the tumor and level 2 lymph nodes. Hepatogastroenterology 2003, 50:1727-30.
9. Nitti D, Marchet A, Mammano E. Extended lymphadenectomy (D2) in patients with early gastric cancer. Eur J Surg Oncol 2005, 31:875-81.
10. Yang YM, Chang JW. Current status and issues in cancer stem cell study. Cancer Invest 2008, 26:741-55.
11. Werner M, Becker KF, Keller G, Höfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001, 127:207-16.
12. Kondo K, Kaneko T, Baba M, Konno H. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull 2007, 30:633-7.
13. Guan-Zhen Y, Ying C, Can-Rong N, Guo-Dong W, Jian-Xin Q, Jie-Jun W. Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 2007, 88:175-83.
14. Aoki R, Yasuda M, Torisu R, Nakamoto J, Yamamoto Y, Ito S. Relationship between lymph node metastasis and E-cadherin expression in submucosal invasive gastric carcinomas with gastric-phenotype. J Med Invest 2007, 54:159-67.
15. Luo ML, Shen XM, Zhang Y. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 2006, 66:11690-9.
16. Freier K, Sticht C, Hofele C. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 2006, 45:118-25.
17. Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA, Daly RJ. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res 2007, 67:9304-14.
18. Xu L, Hui L, Wang S. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001, 61:3176-81.
19. Rhee CH, Hess K, Jabbur J. cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene 1999, 18:2711-17.
20. Vecchi M, Nuciforo P, Romagnoli S. Gene expression analysis of early and advanced gastric cancers. Oncogene 2007, 26:4284-94.
21. Buffart TE, Carvalho B, Hopmans E. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007, 211:45-51.
22. Trautmann K, Steudel C, Grossmann D. Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability. World J Gastroenterol 2005, 11:5993-6.
23. Marchet A, Mocellin S, Belluco C. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 2007, 14:1058-64.
24. Chen YR, Juan HF, Huang HC. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. J Proteome Res 2006, 5:2727-42.
25. Wu MS, Lin YS, Chang YT, Shun CT, Lin MT, Lin JT. Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection. World J Gastroenterol 2005, 11:7405-12.
26. Aggarwal A, Guo DL, Hoshida Y. Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res 2006, 66:232-41.
27. Howell LP, DeNardo SJ, Levy NB, Lund J, DeNardo GL. Immunohistochemical staining of metastatic ductal carcinomas of the breast by monoclonal antibodies used in imaging and therapy: a comparative study. Int J Biol Markers 1995, 10:129-35.
28. Kao YR, Shih JY, Wen WC. Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 2003, 9:2807-16.
29. Chang YW, Chen SC, Cheng EC. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer 2005, 116:243-52.
30. Luo ML, Wang MR. CTTN (EMS1): an oncogene contributing to the metastasis of esophageal squamous cell carcinoma. Cell Res 2007, 17:298-300.
31. Ammer AG, Weed SA. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton 2008, 65:687-707.
32. Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008, 265:157-66.
33. Chiang WL, Chu SC, Yang SS. The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. Cancer Lett 2002, 188:199-205.
34. Ki DH, Jeung HC, Park CH. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 2007, 121:2005-12.